Clinical Trials on Arthrosis in Argentina

Total 226 results

Gema Biotech S.A.
QUID Quality in Drugs and Devices Latin American Consulting SRL

Unknown

Long Term Efficacy, Safety and Immunogenicity of Enerceptan in Rheumatoid Arthritis ( GEMENE002 )

Rheumatoid Arthritis

Argentina
Gema Biotech S.A.
QUID Quality in Drugs and Devices Latin American Consulting SRL

Completed

Efficacy, Safety and Immunogenicity of Enerceptan Compared to Enbrel in Rheumatoid Arthritis (GEMENE)

Rheumatoid Arthritis

Argentina
Fisiatria y Traumatología
American Association of Orthopaedic Medicine

Completed

Changes in Cytokine Levels After Dextrose Injection in Stage IV Knee Osteoarthritis

Osteoarthritis, Knee

Argentina
Promedon

Active, not recruiting

New Hydroxyethyl Cellulose Hydrogel for the Treatment of the Pain of Knee Arthrosis (PROMGEL-OA)

Pain | Osteoarthritis, Knee

Argentina
Dharma Bioscience

Active, not recruiting

Measuring Synovial Fluid Components

Knee Osteoarthritis

Argentina
Clinica Universitaria Reina Fabiola, Universidad...

Recruiting

The Role of the Proprioceptive Training in Functional Recovery of Patient With Thumb Base Osteoarthritis

Thumb Osteoarthritis

Argentina, Spain
Universidad Nacional de Rosario

Completed

Biological Response of Stage IV Knee Osteoarthritis to Serial 12.5% Dextrose

Knee Osteoarthritis

Argentina
Liga Panamericana de Asociaciones de Reumatologia...

Recruiting

PANLAR's Latin American Registry of Rheumatic Patients Treated With Jak Inhibitors (PREJAK)

Arthritis, Rheumatoid | Arthritis, Psoriatic | Spondyloarthritis

Argentina
Pfizer

Completed

Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or Infliximab (ANTIBODY-RA)

Rheumatoid Arthritis

United States, Turkey, Bulgaria, Argentina, Australia
Universidad Nacional de Entre Rios
National Council of Scientific and Technical Research, Argentina

Recruiting

Effectiveness of Platelet-rich Plasma Treatment of Knee Osteoarthritis

Knee Osteoarthritis

Argentina
The Foundation for Orthopaedics and Regenerative...

Recruiting

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for RA

Rheumatoid Arthritis

Antigua and Barbuda, Argentina, Mexico
Hospital Nacional Profesor Alejandro Posadas

Completed

Comparison Between Rebamipide 2% Versus Autologous Serum

Dry Eye Syndromes | Sjögren Syndrome

Argentina
Hoffmann-La Roche

Completed

A Non-interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Argentina
Hospital Nacional Profesor Alejandro Posadas

Completed

Amniotic Membrane Treatment for Hyposecretory Dry Eye

Dry Eye Syndromes | Sjogren Syndrome With Keratoconjunctivitis

Argentina
Biogen

Terminated

104RA204 Assessment of the Safety and Efficacy of BG9924 in Rheumatoid Arthritis (RA) Participants (RESPOND-EXT)

Rheumatoid Arthritis

Argentina, Brazil, Hungary, Mexico, Poland, Romania, Russian Federation, United Kingdom
Biogen

Completed

Assessment Of The Safety And Efficacy Of BG9924 In Rheumatoid Arthritis (RA) Participants (RESPOND)

Rheumatoid Arthritis

Argentina, Mexico, Romania, Brazil, Hungary, Poland, Russian Federation, United Kingdom
Eli Lilly and Company

Completed

A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis (RA)

Rheumatoid Arthritis

China, Argentina, Brazil
Novartis Pharmaceuticals

Terminated

Safety & Efficacy of Canakinumab (ACZ885) in Patients With Frequent Flares for Whom Nonsterodial Anti-Inflammatory Drug (NSAIDs) and/ or Colchicine Are Contraindicated, Not Tolerated or Ineffective

Gouty Arthritis

China, Poland, Singapore, Argentina
Hoffmann-La Roche

Completed

A Study to Evaluate Pharmacokinetics and Safety of Tocilizumab (RoActemra/Actemra) in Participants Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis (sJIA)

Juvenile Idiopathic Arthritis

Belgium, Canada, United States, Argentina, Poland, Spain, Germany, Hungary
Pfizer
Amgen

Completed

Open-Label Study Comparing Etanercept to Conventional Disease Modifying Antirheumatic Drug (DMARD) Therapy

Rheumatoid Arthritis

Chile, Colombia, Argentina, Mexico, Panama
Hoffmann-La Roche

Completed

A Study Assessing the Safety and Efficacy of Subcutaneous RoActemra/Actemra Alone or in Combination With Non-biologic Antirheumatics in Rhuematoid Arthritis Patients in Latin America With Inadequate Response to Non-biologic Antirheumatic Drugs.

Rheumatoid Arthritis

Brazil, Colombia, Argentina, Dominican Republic, Mexico, Venezuela
Sanofi
Regeneron Pharmaceuticals

Recruiting

A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)

Juvenile Idiopathic Arthritis

Argentina, Bulgaria, Canada, Finland, France, Germany, Ireland, Italy, Russian Federation, Spain, United Kingdom
Neovacs

Completed

Immunogenicity and Safety of TNFa Kinoid in Rheumatoid Arthritis With Secondary Resistance to TNFa Antagonists

Rheumatoid Arthritis

Belgium, France, Bulgaria, Argentina, Croatia, Chile, Romania
Array Biopharma, now a wholly owned subsidiary...

Completed

A Study of ARRY-438162 in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Brazil, Argentina, United States, Poland, Hungary, Peru, Romania
Hoffmann-La Roche

Completed

A Study of Decreased Dose Frequency in Participants With Systemic Juvenile Arthritis Who Experience Laboratory Abnormalities During Treatment With RoActemra/Actemra (Tocilizumab)

Juvenile Idiopathic Arthritis

Canada, Mexico, United States, Argentina, Germany, Israel, Italy, Russian Federation, Spain, United Kingdom
EMD Serono Research & Development Institute, Inc.
Nordic Bioscience A/S

Completed

A Study to Investigate the Safety and Effectiveness of Different Doses of Sprifermin in Participants With Osteoarthritis of the Knee (FORWARD)

Osteoarthritis, Knee

Estonia, Romania, Hong Kong, Czechia, Denmark, Poland, Argentina, United States
Nuon Therapeutics, Inc.

Completed

Safety and Efficacy Study of Tranilast in Patients With Active Rheumatoid Arthritis (RA)

Active Rheumatoid Arthritis

United Kingdom, United States, Argentina, Bulgaria, Serbia, Germany, Mexico, Czech Republic
Janssen Research & Development, LLC

Completed

An Efficacy And Safety Study of CNTO 6785 In Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Rheumatoid Arthritis

Poland, Argentina, Colombia, Philippines, Russian Federation, Thailand, Czech Republic
Bristol-Myers Squibb

Completed

Study to Characterize the Pharmacokinetics of a Single Dose of SC Abatacept 125 mg Using the BD Autoinjector or the Prefilled Syringe

Rheumatoid Arthritis

Argentina, United States, Peru, South Africa, Mexico
Hoffmann-La Roche

Completed

A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.

Rheumatoid Arthritis

Colombia, Mexico, Chile, Ecuador, Argentina, Brazil, Peru, Venezuela, Uruguay, El Salvador
Bristol-Myers Squibb

Completed

PoC in Rheumatoid Arthritis With Methotrexate

Rheumatoid Arthritis, NOS

Taiwan, France, United States, Spain, Argentina, Mexico, Czech Republic, Korea, Republic of
Debiopharm International SA

Recruiting

Study to Assess Safety, Tolerability and Efficacy of Afabicin in The Treatment of Participants With Bone or Joint Infection Due to Staphylococcus

Bone or Joint Infection

United States, Ukraine, Argentina, South Africa, Georgia
Eli Lilly and Company

Terminated

Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)

Rheumatoid Arthritis

Argentina, United States, Czechia, Puerto Rico, Russian Federation, Poland
Novartis Pharmaceuticals

Active, not recruiting

Safety and Efficacy of RHH646 for Knee Osteoarthritis

Osteoarthritis, Knee

Denmark, United States, Poland, Argentina, Spain
Bristol-Myers Squibb

Completed

Proof-of-Concept Study With BMS-817399 to Treat Moderate to Severe Rheumatoid Arthritis (RA)

Rheumatoid Arthritis

Korea, Republic of, United States, Mexico, Spain, Russian Federation, South Africa, Argentina
Pfizer

Completed

Dose-Escalating Multiple Dose Study of PD-0360324 in Combination With Methotrexate in Patients With Rheumatoid Arthritis

Arthritis, Rheumatoid

United States, Czech Republic, Bulgaria, Poland, Slovakia, Spain, Mexico, Argentina
UCB BIOSCIENCES GmbH
PRA Health Sciences

Completed

Pediatric Arthritis Study of Certolizumab Pegol (PASCAL)

Polyarticular-course Juvenile Idiopathic Arthritis (JIA)

United States, Argentina, Brazil, Canada, Chile, Mexico, Russian Federation
Bristol-Myers Squibb

Completed

Phase IIIB Subcutaneous Missed Dose Study

Rheumatoid Arthritis

Argentina, Mexico, United States, South Africa, Canada
Sanofi
Regeneron Pharmaceuticals

Completed

An Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA) (SKYPP)

Juvenile Idiopathic Arthritis

United States, Argentina, Canada, Chile, Czechia, Finland, France, Germany, Italy, Mexico, Netherlands, Poland, Russian Federation, Spain, United Kingdom
Janssen Research & Development, LLC

Recruiting

A Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis (PSUMMIT-Jr)

Arthritis, Juvenile

United States, France, United Kingdom, Turkey, Spain, Argentina, Germany, Italy, Poland, Denmark
Pfizer

Completed

Effects of Tofacitinib (CP-690,550) on Magnetic Resonance Imaging (MRI)- Assessed Joint Structure In Early Rheumatoid Arthritis (RA)

Rheumatoid Arthritis

United States, Mexico, Argentina, Chile, Croatia, Czech Republic, Hungary, Poland, Puerto Rico
MedImmune LLC
MedImmune Ltd

Completed

A Study of Mavrilimumab in Subjects With Moderate-to-Severe Rheumatoid Arthritis

Rheumatoid Arthritis

Bulgaria, Poland, Russian Federation, South Africa, Spain, Estonia, Hungary, Ukraine, Argentina, Chile, Germany, Serbia, Czech Republic, Colombia
Janssen Research & Development, LLC

Active, not recruiting

A Study to Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid Arthritis (DAISY)

Arthritis, Rheumatoid

United Kingdom, United States, Germany, Argentina, Hungary, Poland
Hoffmann-La Roche

Completed

Extension Study Evaluating the Safety and Efficacy of Subcutaneous Tocilizumab (RoActemra/Actemra) Administration in Systemic and Polyarticular-Course Juvenile Idiopathic Arthritis

Juvenile Idiopathic Arthritis

United States, Canada, United Kingdom, Brazil, Germany, Italy, Russian Federation, Spain, Australia, France, Mexico, Argentina
Hoffmann-La Roche

Completed

A Study of Subcutaneously Administered Tocilizumab in Participants With Systemic Juvenile Idiopathic Arthritis

Juvenile Idiopathic Arthritis

United States, Canada, United Kingdom, Brazil, Argentina, Germany, Italy, Russian Federation, Spain, Mexico, Australia, France
Janssen Research & Development, LLC

Completed

A Study of JNJ-40346527 in Patients With Active Rheumatoid Arthritis Despite Disease-modifying Antirheumatic Drug Therapy

Arthritis, Rheumatoid

Poland, Ukraine, Chile, Korea, Republic of, Singapore, Russian Federation, Argentina, Bulgaria, Hungary, Czech Republic
Hoffmann-La Roche

Completed

A Study of Subcutaneously (SC) Administered Tocilizumab (TCZ) in Participants With Polyarticular-Course Juvenile Idiopathic Arthritis (pJIA) (JIGSAW 117)

Juvenile Idiopathic Arthritis

Spain, Mexico, Germany, United States, Russian Federation, Australia, Italy, Argentina, Brazil, Canada, France, United Kingdom
Pfizer
Emergent Product Development Seattle LLC

Completed

Study Evaluating The Efficacy And Safety Of SBI-087 In Seropositive Subjects With Active Rheumatoid Arthritis

Active Rheumatoid Arthritis

United States, Canada, Serbia, Japan, Spain, Poland, Hungary, Argentina, Chile, Mexico
Eli Lilly and Company

Completed

A Study for Patients With Active Rheumatoid Arthritis Despite Ongoing Methotrexate Therapy

Rheumatoid Arthritis

United States, Mexico, Hungary, India, Argentina, Chile, Ukraine, Australia, Romania, Germany, Poland, Slovakia
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Safety and Effectiveness Study of RWJ-445380 Cathepsin-S Inhibitor in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Rheumatoid Arthritis

United States, Poland, Germany, Mexico, Brazil, Czech Republic, Argentina

Clinical Trials on Arthrosis in Argentina

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Macedonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations